So it starts… The IPT is in Südtirol in the wonderful town of Kaltern ⛰️ Shoutout to @DAndergassen for the organization! Looking forward to our wine tasting, hiking at Lake Kaltern and of course some science 😊
🆕@ScienceMagazine
Cool science and important discovery for why people with heart failure have a sleep disorder:
Immune-mediated loss of pineal gland innervation
https://t.co/PCFje9QTmA
https://t.co/TjtfVzGs3H
@ScienceVisuals
Wonderful news! You can still submit your abstract for the Young DZHK Retreat 2023 🥳 Great science and this year, even more time for networking and having fun!! Don't miss the chance and secure your seat now 👇
https://t.co/9uo8Xr2gWW
This was our most popular recipe last year: San Francisco-Style Vietnamese American Garlic Noodles. Readers visited this gem more than 1.2 million times. That’s a lot of garlic. https://t.co/qTxZhgywQG
🥳😀We are very happy that our collaborative research center on "Cardiovascular noncoding RNAs" @trr267 is extended for the next 4 years! Many thanks to @dfg_public for allowing us to continue exploring the RNA world with our great team @goetheuni @LMU_Uni @MHH_life @mpi_hlr
‼️Science on friday organized by the YoungDZHK‼️
Chairs @SFG_Ffm& @LarsMaeg
*Spatial multi-omic map of human myocardial infarction | @KuppeChristoph
*The senescence niche in the ageing heart | @LukTmbr
*Targeted in situ sequencing for human atherosclerosis | @Jessica_Pauli_
An an easily to understand coverage for everyone on our study on German news channel. Monatelange Winterruhe: Wie Bären der Thromboseforschung helfen | https://t.co/rfHQYjyt2S @LMU_Uniklinikum @dzhk_germany@FrobertOle https://t.co/3fLzVXCkdQ
I came from hospital with a remodulated immunosuppressive therapy, but after a week the blood virus concentration skyrocketed reaching the double of the previous week value (765k copies/ml vs 359 copies/ml) and this is seriously bad, because it means my organism doesn't react to the standard therapy (which is actually an anti-therapy).
Since this is a quite rare condition (as most part of patients react well to the immunodepressant reduction), it means mine is a severe pathology seriously putting at risk the new kidney. I read tens of papers from everywhere in the world and apparently there's no effective anti-viral drugs agains this virus (Polyomavirus BK) but there are potential cocktails along with IVIGs, intravenous immunoglobulines.
I suspect I need help with urgency from anyone could know very specific information about experimental treatments for this virus in a post-transplant condition that can avoid the graft loss. Obviously, being in Italy, the quickest help can come from here or from the closest countries, but contacts are important too across hospitals and clinics around the world, so that's why this is a tweet in English (on top of the fact that the account has always posting in English).
Thanks in advance for your help and support as usual.
"Wir müssen (...) die #Zukunft sehen wie sie ist und darin einen guten #Platz finden" 🙌 Diesen Appell an #Bibliotheken wird @wilddueck beim #BLT22 näher beleuchten💡
Jetzt anmelden unter https://t.co/SqVOrQC2on 🎟
Zum Teaser unseres Keynote Speakers ⤵
https://t.co/2BWvJ9NBTk
A warm welcome to our new partnersite co-spokespersons Heidelberg/Mannheim @ChristinaMerte7 and Göttingen @MonikaSadlonova
and
congratulations to @SoniaSingh0105 for being elected as one of our co-spokespersons!!! 🥳
Great to have you all in our team!